Assessment of Hospitalizations and Emergency Department Visits After Chimeric Antigen Receptor T-Cell Therapy Among Commercially Insured Patients.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 35511173.
- Also identified by DOI 10.1001/jamaoncol.2022.1044 and PMC identifier 9073656.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This cohort study examines the cumulative incidence of rehospitalizations and emergency department visits during the first 12 months after hospitalization for chimeric antigen receptor T-cell infusion among commercially insured patients.
Medical subject headings
- Receptors, Chimeric Antigen